Annexon Biosciences's total assets for Q1 2026 were $262.89M, a decrease of -5.29% from the previous quarter. ANNX total liabilities were $58.35M for the fiscal quarter, a -11.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.